z-logo
Premium
Purified calcium channels have three allosterically coupled drug receptors
Author(s) -
Striessnig J.,
Goll A.,
Moosburger K.,
Glossmann H.
Publication year - 1986
Publication title -
febs letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.593
H-Index - 257
eISSN - 1873-3468
pISSN - 0014-5793
DOI - 10.1016/0014-5793(86)80327-1
Subject(s) - allosteric regulation , dihydropyridine , chemistry , receptor , diltiazem , stereochemistry , calcium channel , binding site , voltage dependent calcium channel , calcium , biophysics , biochemistry , biology , organic chemistry
(−)‐[ 3 H]Desmethoxyverapamil and (+)‐[ 3 P]PN 200‐110 were employed to characterize phenylalkylamineselective and 1,4‐dihydropyridine‐selective receptors on purified Ca 2+ channels from guinea‐pig skeletal muscle t ‐tubules. In contrast to the membrane‐bound Ca 2+ channel, d‐ cis ‐diltiazem (EC 50 = 4.5 ± 1.7 μM) markedly stimulated the binding of (+)‐[ 3 H]PN 200‐110 to the purified ionic pore. In the presence of 100 μM d‐ cis ‐diltiazem (which binds to the benzothiazepine‐selective receptors) the B max for (+)‐[ 3 H]PN 200‐110 increased from 497 ± 81 to 1557 ± 43 pmol per mg protein, whereas the K d decreased from 8.8 ± 1.7 to 4.7 ± 1.8 nM at 25°C. P‐ cis ‐Diltiazem was inactive. (−)‐Desmethoxyverapamil, which is a negative heterotropic allosteric inhibitor of (+)‐[ 3 H]IN 200‐110 binding to membrane‐bound channels, stimulated 1,4‐dihydropyridine binding to the isolated channel. (−)‐[ 3 H]Desmethoxyverapamil binding was stimulated by antagonistic 1,4‐dihydropyridines [(+)‐PN 200‐110 ⪢(−)(CR)‐202‐791 ⪢(+)(4 R )‐Bay K 8644] whereas the agonistic enantiomers (+)( S )‐202‐791 and (−)(4 S )‐Bay K 8644 were inhibitory and (−)‐PN 200‐110 was inactive. The results indicate that three distinct drug‐receptor sites exist on the purified Ca 2+ channel, two of which are shown by direct labelling to be reciprocally allosterically coupled.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here